Pages that link to "Q71167703"
Jump to navigation
Jump to search
The following pages link to Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency (Q71167703):
Displaying 50 items.
- In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer (Q24532255) (← links)
- Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles (Q24539210) (← links)
- Gene therapy for severe combined immunodeficiency: are we there yet? (Q24680426) (← links)
- Human genetic basis of interindividual variability in the course of infection (Q26775894) (← links)
- Somatic mosaicism in the human genome (Q26823199) (← links)
- Mechanisms and consequences of somatic mosaicism in humans (Q28205052) (← links)
- Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion (Q28303984) (← links)
- ZBTB1 is a determinant of lymphoid development (Q28585897) (← links)
- Revertant mosaicism in skin: natural gene therapy (Q28741264) (← links)
- Severe combined immunodeficiencies (SCID) (Q29042256) (← links)
- Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa (Q33226033) (← links)
- Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome (Q33378512) (← links)
- Revertant mosaicism in human genetic disorders (Q33682876) (← links)
- Fetal hematopoietic stem cell transplantation (Q33814232) (← links)
- Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo (Q34124290) (← links)
- Primary T-lymphocyte immunodeficiencies (Q34195521) (← links)
- Genotype is an important determinant of phenotype in adenosine deaminase deficiency (Q34263693) (← links)
- Primary immunodeficiency diseases: an experimental model for molecular medicine (Q34284845) (← links)
- Gene therapy for human severe combined immunodeficiencies (Q34326172) (← links)
- Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation (Q34393135) (← links)
- Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. (Q34472144) (← links)
- Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways. (Q34647002) (← links)
- Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings (Q34984944) (← links)
- Somatic gene mutation and human disease other than cancer (Q35088015) (← links)
- Stem cell and genetic therapies for the fetus (Q35214121) (← links)
- Somatic Mosaicism Caused by Monoallelic Reversion of a Mutation in T Cells of a Patient with ADA‐SCID and the Effects of Enzyme Replacement Therapy on the Revertant Phenotype (Q35284944) (← links)
- In vivo reversion to normal of inherited mutations in humans (Q35440872) (← links)
- In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I. (Q35723184) (← links)
- Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes (Q35847830) (← links)
- Expansion of somatically reverted memory CD8 T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. (Q38636132) (← links)
- Survival of the fittest: in vivo selection and stem cell gene therapy (Q36306141) (← links)
- Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1) (Q36384593) (← links)
- RAG-dependent primary immunodeficiencies. (Q36589111) (← links)
- Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome (Q36658022) (← links)
- Update on clinical gene therapy in childhood (Q36978568) (← links)
- Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. (Q37111771) (← links)
- T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34 cells in ADA-deficient SCID neonates. (Q37182935) (← links)
- Unravelling the association of partial T-cell immunodeficiency and immune dysregulation (Q37190443) (← links)
- New approaches for modelling sporadic genetic disease in the mouse (Q37331250) (← links)
- Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa (Q37707008) (← links)
- Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy (Q37782256) (← links)
- Gene therapy for primary immunodeficiencies: current status and future prospects (Q38213501) (← links)
- Inborn errors of metabolism underlying primary immunodeficiencies (Q38235840) (← links)
- Mosaicism in health and disease - clones picking up speed (Q38784278) (← links)
- Unexpected and variable phenotypes in a family with JAK3 deficiency (Q40758303) (← links)
- RAG1 reversion mosaicism in a patient with Omenn syndrome (Q41437749) (← links)
- A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8 T cells (Q41471275) (← links)
- Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency (Q41521392) (← links)
- Molecular biology of Fanconi anemia (Q41689624) (← links)
- Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient (Q41872915) (← links)